Mesenchymal stem cells at the intersection of cell and gene therapy

Timothy J. Myers, Froilan Granero-Molto, Lara Longobardi, Tieshi Li, Yun Yan, Anna Spagnoli

Research output: Contribution to journalReview article

77 Citations (Scopus)

Abstract

Importance of the field : Mesenchymal stem cells have the ability to differentiate into osteoblasts, chondrocytes and adipocytes. Along with differentiation, MSCs can modulate inflammation, home to damaged tissues and secrete bioactive molecules. These properties can be enhanced through genetic-modification that would combine the best of both cell and gene therapy fields to treat monogenic and multigenic diseases. Areas covered in this review: Findings demonstrating the immunomodulation, homing and paracrine activities of MSCs followed by a summary of the current research utilizing MSCs as a vector for gene therapy, focusing on skeletal disorders, but also cardiovascular disease, ischemic damage and cancer. What the reader will gain: MSCs are a possible therapy for many diseases, especially those related to the musculoskeletal system, as a standalone treatment, or in combination with factors that enhance the abilities of these cells to migrate, survive or promote healing through anti-inflammatory and immunomodulatory effects, differentiation, angiogenesis or delivery of cytolytic or anabolic agents. Take home message: Genetically-modified MSCs are a promising area of research that would be improved by focusing on the biology of MSCs that could lead to identification of the natural and engrafting MSC-niche and a consensus on how to isolate and expand MSCs for therapeutic purposes.

Original languageEnglish (US)
Pages (from-to)1663-1679
Number of pages17
JournalExpert Opinion on Biological Therapy
Volume10
Issue number12
DOIs
StatePublished - Dec 1 2010

Fingerprint

Gene therapy
Cell- and Tissue-Based Therapy
Stem cells
Mesenchymal Stromal Cells
Genetic Therapy
Musculoskeletal system
Anabolic Agents
Musculoskeletal System
Immunomodulation
Osteoblasts
Chondrocytes
Research
Adipocytes
Anti-Inflammatory Agents
Cardiovascular Diseases
Therapeutics
Tissue
Inflammation
Molecules
Neoplasms

Keywords

  • gene therapy
  • genetic engineering
  • genetic modifications
  • immunomodulatory
  • mesenchymal stem cell
  • paracrine effects
  • skeletal disorders

ASJC Scopus subject areas

  • Pharmacology
  • Drug Discovery
  • Clinical Biochemistry

Cite this

Mesenchymal stem cells at the intersection of cell and gene therapy. / Myers, Timothy J.; Granero-Molto, Froilan; Longobardi, Lara; Li, Tieshi; Yan, Yun; Spagnoli, Anna.

In: Expert Opinion on Biological Therapy, Vol. 10, No. 12, 01.12.2010, p. 1663-1679.

Research output: Contribution to journalReview article

Myers, Timothy J. ; Granero-Molto, Froilan ; Longobardi, Lara ; Li, Tieshi ; Yan, Yun ; Spagnoli, Anna. / Mesenchymal stem cells at the intersection of cell and gene therapy. In: Expert Opinion on Biological Therapy. 2010 ; Vol. 10, No. 12. pp. 1663-1679.
@article{bac552d66ff94b6990b59a8c16f697b7,
title = "Mesenchymal stem cells at the intersection of cell and gene therapy",
abstract = "Importance of the field : Mesenchymal stem cells have the ability to differentiate into osteoblasts, chondrocytes and adipocytes. Along with differentiation, MSCs can modulate inflammation, home to damaged tissues and secrete bioactive molecules. These properties can be enhanced through genetic-modification that would combine the best of both cell and gene therapy fields to treat monogenic and multigenic diseases. Areas covered in this review: Findings demonstrating the immunomodulation, homing and paracrine activities of MSCs followed by a summary of the current research utilizing MSCs as a vector for gene therapy, focusing on skeletal disorders, but also cardiovascular disease, ischemic damage and cancer. What the reader will gain: MSCs are a possible therapy for many diseases, especially those related to the musculoskeletal system, as a standalone treatment, or in combination with factors that enhance the abilities of these cells to migrate, survive or promote healing through anti-inflammatory and immunomodulatory effects, differentiation, angiogenesis or delivery of cytolytic or anabolic agents. Take home message: Genetically-modified MSCs are a promising area of research that would be improved by focusing on the biology of MSCs that could lead to identification of the natural and engrafting MSC-niche and a consensus on how to isolate and expand MSCs for therapeutic purposes.",
keywords = "gene therapy, genetic engineering, genetic modifications, immunomodulatory, mesenchymal stem cell, paracrine effects, skeletal disorders",
author = "Myers, {Timothy J.} and Froilan Granero-Molto and Lara Longobardi and Tieshi Li and Yun Yan and Anna Spagnoli",
year = "2010",
month = "12",
day = "1",
doi = "10.1517/14712598.2010.531257",
language = "English (US)",
volume = "10",
pages = "1663--1679",
journal = "Expert Opinion on Biological Therapy",
issn = "1471-2598",
publisher = "Elsevier BV",
number = "12",

}

TY - JOUR

T1 - Mesenchymal stem cells at the intersection of cell and gene therapy

AU - Myers, Timothy J.

AU - Granero-Molto, Froilan

AU - Longobardi, Lara

AU - Li, Tieshi

AU - Yan, Yun

AU - Spagnoli, Anna

PY - 2010/12/1

Y1 - 2010/12/1

N2 - Importance of the field : Mesenchymal stem cells have the ability to differentiate into osteoblasts, chondrocytes and adipocytes. Along with differentiation, MSCs can modulate inflammation, home to damaged tissues and secrete bioactive molecules. These properties can be enhanced through genetic-modification that would combine the best of both cell and gene therapy fields to treat monogenic and multigenic diseases. Areas covered in this review: Findings demonstrating the immunomodulation, homing and paracrine activities of MSCs followed by a summary of the current research utilizing MSCs as a vector for gene therapy, focusing on skeletal disorders, but also cardiovascular disease, ischemic damage and cancer. What the reader will gain: MSCs are a possible therapy for many diseases, especially those related to the musculoskeletal system, as a standalone treatment, or in combination with factors that enhance the abilities of these cells to migrate, survive or promote healing through anti-inflammatory and immunomodulatory effects, differentiation, angiogenesis or delivery of cytolytic or anabolic agents. Take home message: Genetically-modified MSCs are a promising area of research that would be improved by focusing on the biology of MSCs that could lead to identification of the natural and engrafting MSC-niche and a consensus on how to isolate and expand MSCs for therapeutic purposes.

AB - Importance of the field : Mesenchymal stem cells have the ability to differentiate into osteoblasts, chondrocytes and adipocytes. Along with differentiation, MSCs can modulate inflammation, home to damaged tissues and secrete bioactive molecules. These properties can be enhanced through genetic-modification that would combine the best of both cell and gene therapy fields to treat monogenic and multigenic diseases. Areas covered in this review: Findings demonstrating the immunomodulation, homing and paracrine activities of MSCs followed by a summary of the current research utilizing MSCs as a vector for gene therapy, focusing on skeletal disorders, but also cardiovascular disease, ischemic damage and cancer. What the reader will gain: MSCs are a possible therapy for many diseases, especially those related to the musculoskeletal system, as a standalone treatment, or in combination with factors that enhance the abilities of these cells to migrate, survive or promote healing through anti-inflammatory and immunomodulatory effects, differentiation, angiogenesis or delivery of cytolytic or anabolic agents. Take home message: Genetically-modified MSCs are a promising area of research that would be improved by focusing on the biology of MSCs that could lead to identification of the natural and engrafting MSC-niche and a consensus on how to isolate and expand MSCs for therapeutic purposes.

KW - gene therapy

KW - genetic engineering

KW - genetic modifications

KW - immunomodulatory

KW - mesenchymal stem cell

KW - paracrine effects

KW - skeletal disorders

UR - http://www.scopus.com/inward/record.url?scp=78249275567&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78249275567&partnerID=8YFLogxK

U2 - 10.1517/14712598.2010.531257

DO - 10.1517/14712598.2010.531257

M3 - Review article

C2 - 21058931

AN - SCOPUS:78249275567

VL - 10

SP - 1663

EP - 1679

JO - Expert Opinion on Biological Therapy

JF - Expert Opinion on Biological Therapy

SN - 1471-2598

IS - 12

ER -